TXG
NASDAQ
US
10x Genomics, Inc. - Common Stock
$22.33
▲ +$0.28
(+1.27%)
Vol 1.3M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.1B
ROE
-10.3%
Margin
-11.9%
D/E
0.00
Beta
2.24
52W
$7–$20
Wall Street Consensus
22 analysts · Apr 20265
Strong Buy
4
Buy
13
Hold
0
Sell
0
Strong Sell
40.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%
Next Report
May 06, 2026
EPS Estimate: $-0.30
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.30 | — | — |
| Dec 2025 | $-0.21 | $-0.13 | +$0.08 |
| Sep 2025 | $-0.29 | $-0.22 | +$0.07 |
| Jun 2025 | $-0.38 | $0.28 | +$0.66 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -11.6% | -11.6% | -11.6% | -11.6% | -10.3% | -10.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 20.0% | -13.1% | -13.1% | -13.1% | -11.9% | -11.9% |
| Gross Margin | 72.6% | 69.5% | 69.5% | 69.5% | 68.9% | 68.9% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.84 | 5.84 | 5.84 | 5.84 | 4.48 | 4.48 |
Key Ratios
ROA (TTM)
-8.0%
P/S (TTM)
3.22
P/B
2.4
EPS (TTM)
$-0.62
CF/Share
$-1.64
Rev Growth 3Y
+7.6%
52W High
$20.34
52W Low
$6.78
$6.78
52-Week Range
$20.34
How does TXG compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
TXG valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
3.2
▼
16%
below
peers
(3.8)
vs Peers
vs Industry
Pricier
P/B ratio
2.5
▼
34%
below
peers
(3.7)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
TXG profitability vs Life Sciences Tools & Services peers
ROE
-10.3%
▼
214%
below
peers
(-3.3%)
vs Peers
vs Industry
Below avg
Net margin
-11.9%
▼
27%
below
peers
(-9.4%)
vs Peers
vs Industry
Below avg
Gross margin
68.9%
▲
44%
above
peers
(48.0%)
vs Peers
vs Industry
Top tier
ROA
-8.0%
▼
207%
below
peers
(-2.6%)
vs Peers
vs Industry
Below avg
TXG financial health vs Life Sciences Tools & Services peers
D/E ratio
0.0
▼
100%
below
peers
(36.5)
vs Peers
vs Industry
Low debt
Current ratio
4.5
▲
33%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
2.2
▲
58%
above
peers
(1.4)
vs Peers
vs Industry
More volatile
TXG fundamentals radar
TXG
Peer median
Industry
TXG profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio